British Journal of Anaesthesia, 2002, Vol. 88, No. 1 101-123
© 2002 The Board of Management and Trustees of the British Journal of Anaesthesia
Modulation of ß-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action
1Department of Anesthesiology, University Hospital Zurich, Rämistrasse 100, CH-8091 Zurich, Switzerland. 2Institute of Pharmacology and Toxicology, University of Zurich, Switzerland. 3Department of Anesthesiology, University Hospital Lausanne, Switzerland*Corresponding author
This review focuses on the mechanisms and sites of action underlying ß-adrenergic antagonism in perioperative medicine. A large body of knowledge has recently emerged from basic and clinical research concerning the mechanisms of the life-saving effects of ß-adrenergic antagonists (ß-AAs) in high-risk cardiac patients. This article re-emphasizes the mechanisms underlying ß-adrenergic antagonism and also illuminates novel rationales behind the use of perioperative ß-AAs from a biological point of view. Particularly, it delineates new concepts of ß-adrenergic signal transduction emerging from transgenic animal models. The role of the different characteristics of various ß-AAs is discussed, and evidence will be presented for the selection of one specific agent over another on the basis of individual drug profiles in defined clinical situations. The salutary effects of ß-AAs on the cardiovascular system will be described at the cellular and molecular levels. ß-AAs exhibit many effects beyond a reduction in heart rate, which are less known by perioperative physicians but equally desirable in the perioperative care of high-risk cardiac patients. These include effects on core components of an anaesthetic regimen, such as analgesia, hypnosis, and memory function. Despite overwhelming evidence of benefit, ß-AAs are currently under-utilized in the perioperative period because of concerns of potential adverse effects and toxicity. The effects of acute administration of ß-AAs on cardiac function in the compromised patient and strategies to counteract potential adverse effects will be discussed in detail. This may help to overcome barriers to the initiation of perioperative treatment with ß-AAs in a larger number of high-risk cardiac patients undergoing surgery.
Br J Anaesth 2002; 88: 101–23
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Suttner, J. Boldt, A. Mengistu, K. Lang, and J. Mayer Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients Br. J. Anaesth., May 1, 2009; 102(5): 597 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. HARTE and A. K. JAFFER Perioperative beta-blockers in noncardiac surgery: Evolution of the evidence Cleveland Clinic Journal of Medicine, July 1, 2008; 75(7): 513 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kurita, K. Takata, K. Morita, and S. Sato Lipophilic {beta}-adrenoceptor antagonist propranolol increases the hypnotic and anti-nociceptive effects of isoflurane in a swine model Br. J. Anaesth., June 1, 2008; 100(6): 841 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Biccard, J. W. Sear, and P. Foex Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes Br. J. Anaesth., January 1, 2008; 100(1): 23 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Chiu, M. Mansor, A. Majid, C. Marcucci, P. G. Chassot, and D. R. Spahn Anaesthetic management of high-risk cardiac patients undergoing thoracic surgery with the support of intra-aortic balloon pump Br. J. Anaesth., May 1, 2005; 94(5): 688 - 689. [Full Text] [PDF]
|
|
|
|
|
|
C. Garcia, K. Julier, L. Bestmann, A. Zollinger, L. K. von Segesser, T. Pasch, D. R. Spahn, and M. Zaugg Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery Br. J. Anaesth., February 1, 2005; 94(2): 159 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Boldt, C. Brosch, A. Lehmann, S. Suttner, and F. Isgro The Prophylactic Use of the {beta}-Blocker Esmolol in Combination with Phosphodiesterase III Inhibitor Enoximone in Elderly Cardiac Surgery Patients Anesth. Analg., October 1, 2004; 99(4): 1009 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zaugg, C. Schulz, J. Wacker, and M. C. Schaub Sympatho-modulatory therapies in perioperative medicine Br. J. Anaesth., July 1, 2004; 93(1): 53 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zaugg and M. C. Schaub Cellular mechanisms in sympatho-modulation of the heart Br. J. Anaesth., July 1, 2004; 93(1): 34 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zaugg, M. C. Schaub, and P. Foex Myocardial injury and its prevention in the perioperative setting Br. J. Anaesth., July 1, 2004; 93(1): 21 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Marcucci, P.-G. Chassot, J.-P. Gardaz, L. Magnusson, H.-B. Ris, A. Delabays, and D. R. Spahn Fatal myocardial infarction after lung resection in a patient with prophylactic preoperative coronary stenting{dagger} Br. J. Anaesth., May 1, 2004; 92(5): 743 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Spahn and H.-J. Priebe Editorial II: Preoperative hypertension: remain wary? 'Yes'--cancel surgery? 'No' Br. J. Anaesth., April 1, 2004; 92(4): 461 - 464. [Full Text] [PDF]
|
|
|
|
|
|
M. Zaugg, E. Lucchinetti, C. Garcia, T. Pasch, D. R. Spahn, and M. C. Schaub Anaesthetics and cardiac preconditioning. Part II. Clinical implications Br. J. Anaesth., October 1, 2003; 91(4): 566 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-G. Chassot, A. Delabays, and D. R. Spahn Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery Br. J. Anaesth., November 1, 2002; 89(5): 747 - 759. [Abstract] [Full Text] [PDF]
|
|